These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
263 related items for PubMed ID: 14997042
1. Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma. Davidson B, Reich R, Lazarovici P, Ann Flørenes V, Nielsen S, Nesland JM. Breast Cancer Res Treat; 2004 Jan; 83(2):119-28. PubMed ID: 14997042 [Abstract] [Full Text] [Related]
2. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients. Davidson B, Lazarovici P, Ezersky A, Nesland JM, Berner A, Risberg B, Tropé CG, Kristensen GB, Goscinski M, van de Putte G, Reich R. Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863 [Abstract] [Full Text] [Related]
3. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression. Davidson B, Konstantinovsky S, Nielsen S, Dong HP, Berner A, Vyberg M, Reich R. Clin Cancer Res; 2004 Nov 01; 10(21):7335-46. PubMed ID: 15534110 [Abstract] [Full Text] [Related]
4. Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma. Davidson B, Reich R, Lazarovici P, Flørenes VA, Risberg B, Nielsen S, Sert B, Bedrossian C. Lung Cancer; 2004 May 01; 44(2):159-65. PubMed ID: 15084380 [Abstract] [Full Text] [Related]
5. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma. Davidson B, Reich R, Lazarovici P, Nesland JM, Skrede M, Risberg B, Tropé CG, Flørenes VA. Clin Cancer Res; 2003 Jun 01; 9(6):2248-59. PubMed ID: 12796393 [Abstract] [Full Text] [Related]
6. Angiogenic molecule expression is downregulated in effusions from breast cancer patients. Konstantinovsky S, Nielsen S, Vyberg M, Kvalheim G, Nesland JM, Reich R, Davidson B. Breast Cancer Res Treat; 2005 Nov 01; 94(1):71-80. PubMed ID: 16142438 [Abstract] [Full Text] [Related]
7. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer. Zhang Y, Dang C, Ma Q, Shimahara Y. Oncol Rep; 2005 Jul 01; 14(1):161-71. PubMed ID: 15944784 [Abstract] [Full Text] [Related]
8. The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma. Ødegaard E, Staff AC, Abeler VM, Kopolovic J, Onsrud M, Lazarovici P, Davidson B. Hum Pathol; 2007 Jan 01; 38(1):140-6. PubMed ID: 16996570 [Abstract] [Full Text] [Related]
9. Expression of nerve growth factor receptors and their prognostic value in human breast cancer. Descamps S, Pawlowski V, Révillion F, Hornez L, Hebbar M, Boilly B, Hondermarck H, Peyrat JP. Cancer Res; 2001 Jun 01; 61(11):4337-40. PubMed ID: 11389056 [Abstract] [Full Text] [Related]
10. The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma. Davidson B, Konstantinovsky S, Kleinberg L, Nguyen MT, Bassarova A, Kvalheim G, Nesland JM, Reich R. Gynecol Oncol; 2006 Sep 01; 102(3):453-61. PubMed ID: 16494928 [Abstract] [Full Text] [Related]
11. SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions. Bock AJ, Nymoen DA, Brenne K, Kærn J, Davidson B. Hum Pathol; 2012 May 01; 43(5):669-74. PubMed ID: 21855113 [Abstract] [Full Text] [Related]
12. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells. Zhu ZW, Friess H, Wang L, Bogardus T, Korc M, Kleeff J, Büchler MW. Clin Cancer Res; 2001 Jan 01; 7(1):105-12. PubMed ID: 11205897 [Abstract] [Full Text] [Related]
13. Netrin-4 is upregulated in breast carcinoma effusions compared to corresponding solid tumors. Yuan Y, Leszczynska M, Konstantinovsky S, Tropé CG, Reich R, Davidson B. Diagn Cytopathol; 2011 Aug 01; 39(8):562-6. PubMed ID: 20730893 [Abstract] [Full Text] [Related]
14. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival. Davidson B, Hadar R, Stavnes HT, Trope' CG, Reich R. Hum Pathol; 2009 May 01; 40(5):705-13. PubMed ID: 19157507 [Abstract] [Full Text] [Related]
15. Expression of nerve growth factor receptors is correlated with progression and prognosis of human pancreatic cancer. Dang C, Zhang Y, Ma Q, Shimahara Y. J Gastroenterol Hepatol; 2006 May 01; 21(5):850-8. PubMed ID: 16704535 [Abstract] [Full Text] [Related]
16. Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma. Kleinberg L, Dong HP, Holth A, Risberg B, Trope' CG, Nesland JM, Flørenes VA, Davidson B. Hum Pathol; 2009 Jun 01; 40(6):795-806. PubMed ID: 19157506 [Abstract] [Full Text] [Related]
17. Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusions. Davidson B, Xi Z, Klokk TI, Tropé CG, Dørum A, Scheistrøen M, Saatcioglu F. Am J Clin Pathol; 2005 Mar 01; 123(3):360-8. PubMed ID: 15716231 [Abstract] [Full Text] [Related]
18. Nerve growth factor and tyrosine kinase A receptor in oral squamous cell carcinoma: is there an association with perineural invasion? Kolokythas A, Cox DP, Dekker N, Schmidt BL. J Oral Maxillofac Surg; 2010 Jun 01; 68(6):1290-5. PubMed ID: 20363547 [Abstract] [Full Text] [Related]
19. Overexpressions of nerve growth factor and its tropomyosin-related kinase A receptor on chordoma cells. Park JB, Lee CK, Koh JS, Lee JK, Park EY, Riew KD. Spine (Phila Pa 1976); 2007 Aug 15; 32(18):1969-73. PubMed ID: 17700442 [Abstract] [Full Text] [Related]
20. Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer. Ma J, Jiang Y, Jiang Y, Sun Y, Zhao X. J Gastroenterol Hepatol; 2008 Dec 15; 23(12):1852-9. PubMed ID: 19120874 [Abstract] [Full Text] [Related] Page: [Next] [New Search]